Hasil Pencarian - Jonathan A. Ledermann
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 6 hasil dari 6
-
1
First-line treatment of ovarian cancer: questions and controversies to address oleh Jonathan A. Ledermann
Diterbitkan 2018-04-01
Artikel -
2
Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer oleh Jonathan A. Ledermann, Eric Pujade-Lauraine
Diterbitkan 2019-05-01
Artikel -
3
Treatment options in recurrent ovarian cancer: latest evidence and clinical potential oleh Daniela Luvero, Andrea Milani, Jonathan A. Ledermann
Diterbitkan 2014-09-01
Artikel -
4
ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies oleh Jonathan A Ledermann, Ilaria Betella, Maria Del Grande, Francesco Multinu, Cristiana Sessa, Ilaria Colombo, Eleonora Zaccarelli, Federica Tomao, Antonio Gonzalez-Martin
Diterbitkan 2020-11-01
Artikel -
5
Self-supervised deep learning for highly efficient spatial immunophenotypingResearch in context oleh Hanyun Zhang, Khalid AbdulJabbar, Tami Grunewald, Ayse U. Akarca, Yeman Hagos, Faranak Sobhani, Catherine S.Y. Lecat, Dominic Patel, Lydia Lee, Manuel Rodriguez-Justo, Kwee Yong, Jonathan A. Ledermann, John Le Quesne, E. Shelley Hwang, Teresa Marafioti, Yinyin Yuan
Diterbitkan 2023-09-01
Artikel -
6
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum‐based regimen and disease... oleh Ana Oaknin, Amit M. Oza, Domenica Lorusso, Carol Aghajanian, Andrew Dean, Nicoletta Colombo, Johanne I. Weberpals, Andrew R. Clamp, Giovanni Scambia, Alexandra Leary, Robert W. Holloway, Margarita Amenedo Gancedo, Peter C. Fong, Jeffrey C. Goh, David M. O’Malley, Deborah K. Armstrong, Susana Banerjee, Jesus García‐Donas, Elizabeth M. Swisher, Terri Cameron, Lara Maloney, Sandra Goble, Jonathan A. Ledermann, Robert L. Coleman
Diterbitkan 2021-10-01
Artikel